ARCHIVES

NCI-Approved Cancer Center, Cooperative Group Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

October 6, 1978

Remaining DCT Recompetitions

November 7, 1980

FDA Designates Zometa For Priority Review.

November 30, 2001

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999

Bennett, Federal Prosecutors Reach $475,000 Settlement

October 31, 2014